These drugs are just too large to slip through the skin
Food and Drug Administration (FDA) has approved semaglutide (marketed as Wegovy) and Tirzepatide (marketed as Zepbound) specifically for chronic weight management in adults with obesity or overweight individuals with at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol
This will look different for everyone, so its important to find a diet that works best for you (consult with your health provider for individualized nutritional advice)
In addition, studies have linked GLP-1 receptor agonists to skeletal muscle breakdown
Rao says its especially important for patients to understand their plans rules, tiers, and prior authorization requirements before requesting a Zepbound prescription from a healthcare provider
Losurdo G, La Fortezza RF, Iannone A, Contaldo A, Barone M, Ierardi E, et al